发明公开
- 专利标题： NOVEL QUINOLINE-SUBSTITUTED COMPOUND
- 专利标题（中）： 中华人民共和国中华人民共和国
-
申请号： EP14837210.5申请日： 2014-08-22
-
公开(公告)号： EP3037424A1公开(公告)日： 2016-06-29
- 发明人: UNO, Takao , NONOSHITA, Katsumasa , SHIMAMURA, Tadashi
- 申请人： Taiho Pharmaceutical Co., Ltd.
- 申请人地址： 1-27 Kandanishiki-cho Chiyoda-ku Tokyo 101-8444 JP
- 专利权人： Taiho Pharmaceutical Co., Ltd.
- 当前专利权人： Taiho Pharmaceutical Co., Ltd.
- 当前专利权人地址： 1-27 Kandanishiki-cho Chiyoda-ku Tokyo 101-8444 JP
- 代理机构： Hoffmann Eitle
- 优先权： JP2013172746 20130822
- 国际公布： WO2015025936 20150226
- 主分类号： C07D487/14
- IPC分类号： C07D487/14 ; A61K31/519 ; A61K31/55 ; A61P35/00 ; A61P43/00
摘要：
An object to be achieved by the present invention is to provide a novel compound having EGFR inhibitory effects and cell growth inhibitory effects, as well as a medication useful for the prevention and/or treatment of cancer based on the EGFR inhibitory effects.
The present invention provides a compound represented by Formula (I) below, or a salt thereof.
The present invention provides a compound represented by Formula (I) below, or a salt thereof.
公开/授权文献
- EP3037424B1 NOVEL QUINOLINE-SUBSTITUTED COMPOUND 公开/授权日：2017-11-08
信息查询
